In November 2017, the TRUNCATE-TB trial was selected for mention in “Global Investments in Tuberculosis Research and Development: Past, Present, and Future”, a policy paper prepared for the first WHO Global Ministerial Conference on Ending Tuberculosis in the Sustainable Development Era in Moscow, Russia
(apps.who.int/iris/bitstream/10665/259412/1/9789241513326-eng.pdf)
RSS Feed
